Cargando…
c-Jun N-terminal kinase 2 prevents luminal cell commitment in normal mammary glands and tumors by inhibiting p53/Notch1 and breast cancer gene 1 expression
Breast cancer is a heterogeneous disease with several subtypes carrying unique prognoses. Patients with differentiated luminal tumors experience better outcomes, while effective treatments are unavailable for poorly differentiated tumors, including the basal-like subtype. Mechanisms governing mammar...
Autores principales: | Cantrell, Michael A., Ebelt, Nancy D., Pfefferle, Adam D., Perou, Charles M., Van Den Berg, Carla Lynn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494910/ https://www.ncbi.nlm.nih.gov/pubmed/25970777 |
Ejemplares similares
-
Kindlin-2 in myoepithelium controls luminal progenitor commitment to alveoli in mouse mammary gland
por: Wang, Zhenbin, et al.
Publicado: (2023) -
Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy
por: Pfefferle, Adam D., et al.
Publicado: (2015) -
MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells
por: Sánchez-Cid, Lourdes, et al.
Publicado: (2017) -
Id-1 is not expressed in the luminal epithelial cells of mammary glands
por: Uehara, Norihisa, et al.
Publicado: (2003) -
Highly metastatic claudin-low mammary cancers can originate from luminal epithelial cells
por: Rädler, Patrick D., et al.
Publicado: (2021)